{"id":390537,"date":"2020-12-01T08:04:18","date_gmt":"2020-12-01T13:04:18","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=390537"},"modified":"2020-12-01T08:04:18","modified_gmt":"2020-12-01T13:04:18","slug":"i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/","title":{"rendered":"I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">SHANGHAI<\/span> and <span class=\"xn-location\">GAITHERSBURG, Md.<\/span>, <span class=\"xn-chron\">Dec. 1, 2020<\/span> \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the strengthening of its Scientific Advisory Board (&#8220;SAB&#8221;) with the appointment of leading international experts Dr. <span class=\"xn-person\">Chen Dong<\/span> and Dr. <span class=\"xn-person\">Jun Ma<\/span>. Both will contribute their esteemed depth of expertise in immunology and hematology to provide scientific review and advise the Company on research and development programs. \u00a0\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder7416\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1345751\/1.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1345751\/1.jpg\" title=\"\" alt=\"\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>&#8220;We are honored and delighted to welcome Dr. Dong and Dr. Ma to our scientific advisory board,&#8221; said Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Honorary Chairman and Director of I-Mab. &#8220;Dr. Dong is a globally recognized leader in the field of immunology and Dr. Ma is a distinguished pioneer in hematology and oncology. I-Mab will greatly benefit from their experience and expertise in their respective fields as we advance our mission to bring transformational medicines to patients around the world through innovation.&#8221;<\/p>\n<p>&#8220;I-Mab has built a leading position in immuno-oncology and I have been impressed with what this company has been able to accomplish in research and clinical development. I look forward to bringing my expertise to the advisory board and contributing to I-Mab&#8217;s rapid growth, in <span class=\"xn-location\">China<\/span> and <span id=\"spanHghlta772\">globally,&#8221; said<\/span> Dr. <span class=\"xn-person\">Chen Dong<\/span>.<\/p>\n<p>Dr. Dong is currently Professor and Director of the Institute for Immunology at Tsinghua University, and a principal investigator at Shanghai Renji Hospital. He is a fellow of the American Association for the Advancement of Science and a member of the Chinese Academy of Sciences. Dr. Dong specializes in immunology, and his transformative research has led to ground-breaking discoveries in the field of T cell biology and interleukin (IL)-17 family cytokines. His research focuses on understanding the molecular mechanisms whereby immune and inflammatory responses are normally regulated, and to apply this knowledge to the understanding and treatment of autoimmunity and allergy disorders as well as cancer. With over 200 publications, Dr. Dong has been rated a highly cited researcher for seven consecutive years from 2014 to 2020. He is the recipient of several distinguished awards, including the 2009 American Association of Immunologists-BD Bioscience Investigator Award and the 2019 International Cytokine and Interferon Society Biolegend-William E. Paul Award.<\/p>\n<p>&#8220;I-Mab is developing advanced and innovative programs in novel anti-cancer therapies. The company is well-positioned to bring to patients target therapies in areas of significant unmet need, and I am pleased to be joining at such an exciting stage in its <span id=\"spanHghltaa5e\">growth,&#8221; said<\/span> Dr. <span class=\"xn-person\">Jun Ma<\/span>.<\/p>\n<p>Dr. Ma is currently Director of the Harbin Institute of Hematology &amp; Oncology, and Chief Supervisor of Supervisory Committee at the Chinese Society of Clinical Oncology. He started his studies in the <span class=\"xn-org\">University of Tokyo<\/span> Hospital and, over the decades, his research focused on treatments for leukemia and lymphoma. He was the first to establish a culture system for multiple hematopoietic progenitor cells in vitro in <span class=\"xn-location\">China<\/span>. Since 1983, he has used sequential therapy of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) to treat acute promyelocytic leukemia (APL) for about 1200 cases. Dr. Ma has published about 200 articles and conducted 8 China&#8217;s National R&amp;D Programs and 25 provincial or municipal-level projects. He is highly recognized as the leader in hematology in <span class=\"xn-location\">China<\/span>.<\/p>\n<p>Dr. Dong and Dr. Ma join existing SAB members <span class=\"xn-person\">Patricia LoRusso<\/span>, <span class=\"xn-person\">Eric K. Rowinsky<\/span>, <span class=\"xn-person\">Howard L. Weiner<\/span>, <span class=\"xn-person\">Yilong Wu<\/span>, <span class=\"xn-person\">Timothy A. Yap<\/span> and <span class=\"xn-person\">Roy S. Herbst<\/span>.<\/p>\n<p>\n        <b>About I-Mab<\/b>\n      <\/p>\n<p>I-Mab (Nasdaq:\u00a0IMAB) is a dynamic, global biotech company exclusively focused on discovery, development and soon commercialization of novel or highly differentiated biologics in the therapeutic areas of immuno-oncology and autoimmune diseases. The Company&#8217;s mission is to bring transformational medicines to patients around the world through innovation. I-Mab&#8217;s innovative pipeline of more than 10 clinical and pre-clinical stage drug candidates is driven by the Company&#8217;s Fast-to-PoC (Proof-of-Concept) and Fast-to-Market development strategies through internal R&amp;D and global partnerships. The Company is on track to transitioning from a clinical stage biotech company toward a fully integrated global biopharmaceutical company with cutting-edge R&amp;D capabilities, world-class GMP manufacturing facility and commercial capability. I-Mab has offices in\u00a0Beijing,\u00a0Shanghai,\u00a0Hangzhou,\u00a0Hong Kong\u00a0and\u00a0Maryland,\u00a0United States. For more information, please visit\u00a0<u><a target=\"_blank\" href=\"http:\/\/ir.i-mabbiopharma.com\/\" rel=\"nofollow noopener noreferrer\">http:\/\/ir.i-mabbiopharma.com<\/a><\/u>\u00a0and follow I-Mab on <u><a target=\"_blank\" href=\"https:\/\/www.linkedin.com\/company\/i-mab\/\" rel=\"nofollow noopener noreferrer\">LinkedIn<\/a><\/u>, <u><a target=\"_blank\" href=\"https:\/\/twitter.com\/IMabBiopharma\" rel=\"nofollow noopener noreferrer\">Twitter<\/a><\/u>\u00a0and <u><a target=\"_blank\" href=\"https:\/\/mp.weixin.qq.com\/mp\/profile_ext?action=home&amp;__biz=MzI1MDM5MjIyOQ==\" rel=\"nofollow noopener noreferrer\">WeChat<\/a><\/u>.<\/p>\n<p>\n        <b>For more information, please contact:<\/b>\n      <\/p>\n<p>\n        <b>I-Mab<\/b>\n      <\/p>\n<p>Jielun Zhu, Chief Financial Officer<br \/>E-mail: <a target=\"_blank\" href=\"mailto:jielun.zhu@i-mabbiopharma.com\" rel=\"nofollow noopener noreferrer\">jielun.zhu@i-mabbiopharma.com<\/a><br \/>Office line: +86 21 6057 8000<\/p>\n<p>\n        <span class=\"xn-person\">Gigi Feng<\/span>, Chief Communications Officer<br \/>E-mail: <a target=\"_blank\" href=\"mailto:gigi.feng@i-mabbiopharma.com\" rel=\"nofollow noopener noreferrer\">gigi.feng@i-mabbiopharma.com<\/a><br \/>Office line: +86 21 6057 5785<\/p>\n<p>\n        <b>Investor Inquiries:<\/b>\n      <\/p>\n<p>\n        <i>Burns McClellan, Inc. (Americas and <span class=\"xn-location\">Europe<\/span>)<\/i>\n      <\/p>\n<p>\n        <span class=\"xn-person\">Steve Klass<\/span><br \/>\n        <br \/>E-mail: <a target=\"_blank\" href=\"mailto:sklass@burnsmc.com\" rel=\"nofollow noopener noreferrer\">sklass@burnsmc.com<\/a><br \/>Office line: +1 212 213 0006<\/p>\n<p>\n        <i>The Piacente Group, Inc. (<span class=\"xn-location\">Asia<\/span>)<\/i>\n      <\/p>\n<p>\n        <span class=\"xn-person\">Emilie Wu<\/span><br \/>\n        <br \/>E-mail: <a target=\"_blank\" href=\"mailto:emilie@thepiacentegroup.com\" rel=\"nofollow noopener noreferrer\">emilie@thepiacentegroup.com<\/a><br \/>Office line: + 86 21 6039 8363<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/821373\/I_MAB_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/821373\/I_MAB_Logo.jpg\" title=\"I-MAB Logo (PRNewsfoto\/I-Mab Biopharma)\" alt=\"I-MAB Logo (PRNewsfoto\/I-Mab Biopharma)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN07697&amp;sd=2020-12-01\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board-301182310.html\">http:\/\/www.prnewswire.com\/news-releases\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board-301182310.html<\/a><\/p>\n<p>SOURCE  I-Mab<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CN07697&amp;Transmission_Id=202012010800PR_NEWS_USPR_____CN07697&amp;DateId=20201201\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SHANGHAI and GAITHERSBURG, Md., Dec. 1, 2020 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the strengthening of its Scientific Advisory Board (&#8220;SAB&#8221;) with the appointment of leading international experts Dr. Chen Dong and Dr. Jun Ma. Both will contribute their esteemed depth of expertise in immunology and hematology to provide scientific review and advise the Company on research and development programs. \u00a0\u00a0 &#8220;We are honored and delighted to welcome Dr. Dong and Dr. Ma to our scientific advisory board,&#8221; said Dr. Jingwu Zang, Founder, Honorary Chairman and Director of I-Mab. &#8220;Dr. Dong is a globally recognized leader in the field of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-390537","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SHANGHAI and GAITHERSBURG, Md., Dec. 1, 2020 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the strengthening of its Scientific Advisory Board (&#8220;SAB&#8221;) with the appointment of leading international experts Dr. Chen Dong and Dr. Jun Ma. Both will contribute their esteemed depth of expertise in immunology and hematology to provide scientific review and advise the Company on research and development programs. \u00a0\u00a0 &#8220;We are honored and delighted to welcome Dr. Dong and Dr. Ma to our scientific advisory board,&#8221; said Dr. Jingwu Zang, Founder, Honorary Chairman and Director of I-Mab. &#8220;Dr. Dong is a globally recognized leader in the field of &hellip; Continue reading &quot;I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-01T13:04:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1345751\/1.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board\",\"datePublished\":\"2020-12-01T13:04:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\\\/\"},\"wordCount\":783,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1345751\\\/1.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\\\/\",\"name\":\"I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1345751\\\/1.jpg\",\"datePublished\":\"2020-12-01T13:04:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1345751\\\/1.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1345751\\\/1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/","og_locale":"en_US","og_type":"article","og_title":"I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board - Market Newsdesk","og_description":"PR Newswire SHANGHAI and GAITHERSBURG, Md., Dec. 1, 2020 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the strengthening of its Scientific Advisory Board (&#8220;SAB&#8221;) with the appointment of leading international experts Dr. Chen Dong and Dr. Jun Ma. Both will contribute their esteemed depth of expertise in immunology and hematology to provide scientific review and advise the Company on research and development programs. \u00a0\u00a0 &#8220;We are honored and delighted to welcome Dr. Dong and Dr. Ma to our scientific advisory board,&#8221; said Dr. Jingwu Zang, Founder, Honorary Chairman and Director of I-Mab. &#8220;Dr. Dong is a globally recognized leader in the field of &hellip; Continue reading \"I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-01T13:04:18+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1345751\/1.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board","datePublished":"2020-12-01T13:04:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/"},"wordCount":783,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1345751\/1.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/","name":"I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1345751\/1.jpg","datePublished":"2020-12-01T13:04:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1345751\/1.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1345751\/1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-appoints-leading-immunology-and-hematology-experts-to-its-scientific-advisory-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/390537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=390537"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/390537\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=390537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=390537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=390537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}